Nick James
researcherMale0.0Global Dominance: 0.00%
Nick James is a prominent cancer researcher and professor at the Institute of Cancer Research (ICR) in England. He has contributed significantly to the understanding of prostate cancer, particularly in relation to its increasing incidence due to an aging population. In recent discussions, he has emphasized the need for healthcare systems to adapt to the rising number of older individuals at risk for this disease.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Nick James co-led the team that built the AI test to predict which men with prostate cancer would benefit from abiraterone.
New AI test can predict which men will benefit from prostate cancer drug | Prostate cancerThe Guardian·
United Kingdom· 2025-05-30
United Kingdom· 2025-05-30
Nick James is one of the authors of the analysis discussing the increase in prostate cancer cases due to an aging population.
Envelhecimento da população vai disparar casos de câncer de próstata; como proteger os brasileiros?O Estado de S. Paulo (Estadão)·
Liechtenstein· 2025-02-26
Liechtenstein· 2025-02-26
